Tetsuya Tanimoto

5.6k total citations · 1 hit paper
199 papers, 2.9k citations indexed

About

Tetsuya Tanimoto is a scholar working on Economics and Econometrics, Pharmacology and Oncology. According to data from OpenAlex, Tetsuya Tanimoto has authored 199 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Economics and Econometrics, 46 papers in Pharmacology and 31 papers in Oncology. Recurrent topics in Tetsuya Tanimoto's work include Pharmaceutical industry and healthcare (43 papers), Pharmaceutical Economics and Policy (38 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Tetsuya Tanimoto is often cited by papers focused on Pharmaceutical industry and healthcare (43 papers), Pharmaceutical Economics and Policy (38 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Tetsuya Tanimoto collaborates with scholars based in Japan, United Kingdom and United States. Tetsuya Tanimoto's co-authors include Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Satoki Shichijo, Tomohiro Tada, Koichiro Yuji, Soichiro Ishihara, Kazuharu Aoyama, Keigo Matsuo and Yasuo Oshima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tetsuya Tanimoto

185 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images

2018 524 citations Tetsuya Tanimoto et al. profile →

Peers

Countries citing papers authored by Tetsuya Tanimoto

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Tanimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Tanimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Tanimoto more than expected).

Fields of papers citing papers by Tetsuya Tanimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Tanimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Tanimoto. The network helps show where Tetsuya Tanimoto may publish in the future.

Co-authorship network of co-authors of Tetsuya Tanimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Tanimoto. A scholar is included among the top collaborators of Tetsuya Tanimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Tanimoto. Tetsuya Tanimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Japan's Conditional/Time‐Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets 2025 ·Clinical Pharmacology & Therapeutics ·(unknown), Akihiko Ozaki, Yudai Kaneda, Tetsuya Tanimoto	2
2	Nature and Trend of Pharmaceutical Payments to Japanese Board-Certified Neurologists Between 2016 and 2019: A Pre-emergence Analysis Amidst the Development of Next-Generation Alzheimer’s Disease Drugs 2024 ·Cureus ·Rajeev Shrestha, Hiroaki Saito, Erika Yamashita, Sunil Shrestha, Tetsuya Tanimoto, Akihiko Ozaki	1
3	The ‘Chokubi’ phenomenon: young physicians’ exodus from state service to private medicine in Japan 2024 ·QJM ·(unknown), Akihiko Ozaki, Yudai Kaneda, Masaharu Tsubokura, Tetsuya Tanimoto	0
4	Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals 2024 ·Clinical and Translational Science ·(unknown), Frank Moriarty, Akihiko Ozaki, Shai Mulinari, Hiroaki Saito, Tetsuya Tanimoto	2
5	Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019 2023 ·OTO Open ·Anju Murayama, (unknown), Sae Kamamoto, Erika Yamashita, Hiroaki Saito, Toyoaki Sawano, Divya Bhandari, Sunil Shrestha, Eiji Kusumi, Tetsuya Tanimoto, Akihiko Ozaki	6
6	Access to Healthcare Services among Thai Immigrants in Japan: A Study of the Areas Surrounding Tokyo 2023 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), (unknown), Tetsuya Tanimoto, Akihiko Ozaki	5
7	Characteristics of Japanese physician influencers on Twitter during the COVID-19 pandemic and fact-checking their tweets on COVID-19-related drugs 2023 ·Postgraduate Medical Journal ·(unknown), Tetsuya Tanimoto, Sae Kamamoto, Akihiko Ozaki, (unknown), (unknown), Anju Murayama, (unknown), Kazuko Uno	2
8	Difficulty in continuing home care after informal caregiver was exposed to the COVID‐19: A case report 2022 ·SHILAP Revista de lepidopterología ·(unknown), Makoto Yoshida, Divya Bhandari, (unknown), Makoto Kosaka, Tetsuya Tanimoto, Masahiro Kami, Akihiko Ozaki	1
9	Why only me? A case report of a breast cancer patient with unresolved trauma from a past disaster experience developing a mental disorder 2022 ·SHILAP Revista de lepidopterología ·Yudai Kaneda, Arinobu Hori, Yasuhiro Kotera, (unknown), Toyoaki Sawano, (unknown), Tomohiro Kurokawa, Masaharu Tsubokura, Tetsuya Tanimoto, (unknown), (unknown), Akihiko Ozaki	2
10	Implications of end‐of‐life home care compared with hospital‐based care during the COVID‐19 pandemic: A case report 2022 ·SHILAP Revista de lepidopterología ·Ryo Sakamoto, Divya Bhandari, Makoto Yoshida, (unknown), Makoto Kosaka, Akihiko Ozaki, Tetsuya Tanimoto, Masahiro Kami	2
11	Cross-Country Student Perceptions about Online Medical Education during the COVID-19 Pandemic 2022 ·International Journal of Environmental Research and Public Health ·(unknown), Anju Murayama, Yasuhiro Kotera, Divya Bhandari, (unknown), (unknown), Kayo Harada, (unknown), (unknown), Toyoaki Sawano, Yasushi Miyata, Masaharu Tsubokura, Tetsuya Tanimoto, Akihiko Ozaki	18
12	Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019 2022 ·Respiration ·Anju Murayama, (unknown), Hiroaki Saito, Sae Kamamoto, (unknown), (unknown), (unknown), Eiji Kusumi, Binaya Sapkota, Sunil Shrestha, Rajeev Shrestha, Divya Bhandari, Toyoaki Sawano, Erika Yamashita, Tetsuya Tanimoto, Akihiko Ozaki	18
13	Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019 2022 ·International Journal of Environmental Research and Public Health ·Anju Murayama, Sae Kamamoto, Hiroaki Saito, (unknown), Divya Bhandari, (unknown), (unknown), (unknown), Erika Yamashita, Eiji Kusumi, Toyoaki Sawano, Binaya Sapkota, Tetsuya Tanimoto, Akihiko Ozaki	16
14	A Call for Enhanced Healthcare Support for Increasingly Vulnerable Groups of Foreigners in Japan: Insights from a Former Thai-Native Medical Student in Japan 2021 ·Malaysian Journal of Medical Sciences ·(unknown), Akihiko Ozaki, Tetsuya Tanimoto	2
15	Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan 2020 ·Journal of Bone and Joint Surgery ·Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, (unknown), Tetsuya Tanimoto	6
16	Long-term trends of hospital admissions among patients with cancer following the 2015 earthquake: a single institution observational study in Kathmandu, Nepal 2019 ·BMJ Open ·(unknown), Akihiko Ozaki, (unknown), (unknown), Toyoaki Sawano, (unknown), Shuhei Nomura, Claire Leppold, Masaharu Tsubokura, Tetsuya Tanimoto, (unknown)	5
17	Trend in unequal geographical distribution of doctors by age and sex in Japan from 2004 to 2014 2018 ·Public Health ·Tomohiro Morita, Tetsuya Tanimoto, (unknown), Masaharu Tsubokura, Masahiro Kami	6
18	Organophosphate Poisoning and Terrorism 2017 ·Malaysian Journal of Medical Sciences ·Tetsuya Tanimoto, Yasuo Oshima, Koichiro Yuji, Akihiko Ozaki, Masahiro Kami	3
19	Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal 2017 ·Journal of Medical Internet Research ·(unknown), Tetsuya Tanimoto, (unknown), (unknown), (unknown), Atsushi Tanaka, Masahiro Kami, Hiroto Narimatsu	14
20	Sociodemographic patterning of long-term diabetes mellitus control following Japan's 3.11 triple disaster: a retrospective cohort study 2016 ·BMJ Open ·Claire Leppold, Masaharu Tsubokura, Akihiko Ozaki, Shuhei Nomura, Yuki Shimada, Tomohiro Morita, Sae Ochi, Tetsuya Tanimoto, Masahiro Kami, Yukio Kanazawa, Tomoyoshi Oikawa, Sarah Hill	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact